- Home
- VSTE vs ALVR Comparison
VSTE vs ALVR Comparison
Compare VSTE & ALVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTE
- ALVR
- Stock Information
- Founded
- VSTE 2009
- ALVR 2013
- Country
- VSTE Australia
- ALVR United States
- Employees
- VSTE N/A
- ALVR N/A
- Industry
- VSTE
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VSTE
- ALVR Health Care
- Exchange
- VSTE Nasdaq
- ALVR Nasdaq
- Market Cap
- VSTE 30.0M
- ALVR 87.7M
- IPO Year
- VSTE N/A
- ALVR 2020
- Fundamental
- Price
- VSTE $2.42
- ALVR $0.90
- Analyst Decision
- VSTE
- ALVR Sell
- Analyst Count
- VSTE 0
- ALVR 5
- Target Price
- VSTE N/A
- ALVR $1.00
- AVG Volume (30 Days)
- VSTE 14.1K
- ALVR 155.6K
- Earning Date
- VSTE 01-01-0001
- ALVR 11-04-2024
- Dividend Yield
- VSTE N/A
- ALVR N/A
- EPS Growth
- VSTE N/A
- ALVR N/A
- EPS
- VSTE N/A
- ALVR N/A
- Revenue
- VSTE $342,000.00
- ALVR N/A
- Revenue This Year
- VSTE N/A
- ALVR N/A
- Revenue Next Year
- VSTE N/A
- ALVR N/A
- P/E Ratio
- VSTE N/A
- ALVR N/A
- Revenue Growth
- VSTE N/A
- ALVR N/A
- 52 Week Low
- VSTE $0.83
- ALVR $0.58
- 52 Week High
- VSTE $12.00
- ALVR $2.49
- Technical
- Relative Strength Index (RSI)
- VSTE 55.09
- ALVR 69.10
- Support Level
- VSTE $0.83
- ALVR $0.74
- Resistance Level
- VSTE $1.09
- ALVR $0.91
- Average True Range (ATR)
- VSTE 0.10
- ALVR 0.06
- MACD
- VSTE 0.03
- ALVR 0.01
- Stochastic Oscillator
- VSTE 92.08
- ALVR 94.50
About VSTE Vast Renewables Limited
Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.